Benefit and Harm of Intensive Blood Pressure Control by Cardiovascular Risk

医学 血压 不利影响 需要伤害的数量 危险系数 泊松回归 风险评估 绝对风险降低 内科学 比例危险模型 相对风险 重症监护医学 置信区间 急诊医学 需要治疗的数量 环境卫生 人口 计算机安全 计算机科学
作者
Xilan Dong,Qianhui Ling,Xueyan Zhao,Qirui Song,Jun Cai
出处
期刊:Hypertension [Lippincott Williams & Wilkins]
卷期号:82 (8): 1392-1400 被引量:7
标识
DOI:10.1161/hypertensionaha.125.25162
摘要

BACKGROUND: Current guidelines for blood pressure treatment are stratified by cardiovascular disease (CVD) risk levels. However, the impact of CVD risk on the benefits and harms of intensive blood pressure control remains unknown. This study aims to evaluate the cardiovascular benefits and treatment-related adverse events associated with intensive blood pressure control across different CVD risk levels. METHODS: From the STEP trial (Strategy of Blood Pressure Intervention in Older Hypertensive Patients), 8262 patients were stratified by tertiles of baseline 10-year CVD risk. Benefit and harm were determined as a reduction of primary outcomes and an increase of adverse events, respectively. Cox proportional hazard models were used to examine the association between CVD risk and outcome events in each tertile. The Poisson regression model was used to predict the benefits and harms. RESULTS: During a median follow-up of 3.32 years, 333 primary outcomes and 611 adverse events occurred. Within each risk tertile, there were lower rates of the primary outcome in the intensive treatment group (overall hazard ratio, 0.76 [95% CI, 0.61-0.94]), and the hazard ratio for adverse events was 1.1 (95% CI, 0.94-1.28). Patients with higher CVD risk had higher absolute risk reduction of the primary outcome and absolute risk increase of adverse events. The predicted benefit-to-harm ratio differed significantly across each CVD risk tertile but favored intensive control overall. CONCLUSIONS: Higher CVD risk was associated with increased benefit and harm from intensive blood pressure control. Although benefit and harm profiles varied across CVD risk levels, the overall benefit was greater than harm in all risk tertiles.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CipherSage的应助被xiaochaoge采纳,获得10
1秒前
Owen的应助被痴痴的噜采纳,获得10
1秒前
ooooo关注了科研通微信公众号
2秒前
tt关注了科研通微信公众号
2秒前
liuch完成签到,获得积分10
3秒前
冬无青山完成签到,获得积分10
3秒前
牛奶完成签到 ,获得积分10
4秒前
怡然的访文完成签到,获得积分10
4秒前
5秒前
孤独靖柏完成签到,获得积分10
5秒前
领导范儿的应助被科研通管家采纳,获得10
7秒前
7秒前
李健的应助被科研通管家采纳,获得10
7秒前
Jasper的应助被科研通管家采纳,获得10
8秒前
李健的应助被科研通管家采纳,获得10
8秒前
8秒前
SciGPT的应助被原儿采纳,获得10
8秒前
十八寒露的应助被科研通管家采纳,获得10
8秒前
李爱国的应助被科研通管家采纳,获得10
8秒前
ding的应助被科研通管家采纳,获得10
8秒前
顾矜的应助被科研通管家采纳,获得10
8秒前
充电宝的应助被科研通管家采纳,获得10
9秒前
9秒前
汉堡包的应助被科研通管家采纳,获得10
9秒前
9秒前
9秒前
我听见蝉鸣了完成签到,获得积分10
10秒前
吴xl发布了新的文献求助10
10秒前
Hong发布了新的文献求助30
10秒前
10秒前
12秒前
Owen的应助被小羊会飞采纳,获得10
13秒前
科研通AI2S的应助被Rina采纳,获得10
15秒前
15秒前
不安晓曼发布了新的文献求助10
16秒前
Chen116完成签到,获得积分10
17秒前
恭敬完成签到 ,获得积分20
17秒前
Nole的应助被喆喆采纳,获得30
18秒前
英俊的铭的应助被yishu采纳,获得10
18秒前
萌神发布了新的文献求助10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193079
求助须知:如何正确求助?哪些是违规求助? 9579384
关于积分的说明 21865064
捐赠科研通 7792635
什么是DOI,文献DOI怎么找? 3437158
关于科研通互助平台的介绍 2560661
邀请新用户注册赠送积分活动 2483960